ACE2 improves right ventricular function in a pressure overload model.
about
The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series)Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial HypertensionAssociation of plasma angiotensin-(1-7) level and left ventricular function in patients with type 2 diabetes mellitusPI3K/AKT signaling pathway plays a role in enhancement of eNOS activity by recombinant human angiotensin converting enzyme 2 in human umbilical vein endothelial cells.Biventricular remodeling in murine models of right ventricular pressure overloadRestoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension.The Effects of Antigen-Specific IgG1 Antibody for the Pulmonary-Hypertension-Phenotype and B Cells for Inflammation in Mice Exposed to Antigen and Fine Particles from Air Pollution.ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease TherapyTestosterone negatively regulates right ventricular load stress responses in mice.Effect of Angiotensin(1-7) on Heart Function in an Experimental Rat Model of ObesityAntagonism of the thromboxane-prostanoid receptor is cardioprotective against right ventricular pressure overload.Exercise Training Attenuates Right Ventricular Remodeling in Rats with Pulmonary Arterial Stenosis.Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension.Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.Emerging biomarkers for heart failure: an update.Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy.Echocardiographic assessment of the right heart in mice.Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges.Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension.Morphologic and Functional Changes in Right-Sided Cardiac Chambers in Patients With Chronic Liver Disease and Normal Pulmonary Artery Pressure.Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis.ACE2 and Ang-(1-7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response.Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy.Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy.rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling.Neurohormonal modulation as therapeutic avenue for right ventricular dysfunction in pulmonary artery hypertension: till the dawn, waiting
P2860
Q27013946-C0C8DFBF-FA20-47AA-BE8F-10819F4B0745Q28085007-FC751769-115B-45D2-9F5F-893E5E17237AQ34729883-4410BA87-8F58-4E77-A0ED-A550A38C09C8Q34733168-0E17AF49-69E7-4FFB-AEB3-E5B7D09B1023Q34923598-BFE1C1C3-541B-4EB3-AC1C-AC23207087D5Q34945488-F8A40FDA-ED0F-4C47-BD12-C6116B89EE18Q35665034-4E5C4EA1-79DE-4B81-9E6B-0EE693A25E5DQ35760437-91BA0B66-01E4-4208-8BF4-6D1F7D4AFD5DQ36366090-1EDDAEF2-3A7A-4AD6-B66D-6214F4EF3BCBQ36387444-F77FED69-D574-4905-A0DC-948C66AB8EF6Q36908852-18B3C3DF-9AEE-4220-AE4B-00C61EEAC65EQ37471203-8794C136-8867-46D8-BC1E-68F57046B13AQ37688533-9FE1FCA5-691F-4823-90BD-1FF66050B4BFQ38059198-2107BB34-1CA8-42C6-A228-DFE28FB90065Q38207841-BAD90D1A-1EA0-40FC-A33F-370F1DA0860DQ38249995-8EC7C89E-ECE5-4D70-BF8E-75BCB86DD295Q38524717-6EF2A198-F530-402F-B742-76E25D4107E7Q38833632-3CE3A2AC-3EEF-4CF9-A349-414B67AC649DQ42124925-EBAEFBD1-3D20-4819-9D0E-09471EAD81E5Q46336560-BD1CE991-CB89-4265-9ADD-582C645FFCECQ48368623-9B582653-7112-44CF-9F66-010946D12165Q51622699-1352AE97-6A1C-4483-8E69-DAC4CD08D528Q52963656-F6DDAC7E-91CA-4041-A226-7FC683B62420Q53594442-1AF0C03A-E8DC-49BE-BEFE-E3D1A8011355Q55294754-A19032A8-B71F-4FEE-B32F-08DEC47F9064Q55343523-C5089E31-C7BF-4B50-96C5-9C08F73B4F3CQ58804808-0B846864-2207-4158-9C74-057C5C7E182F
P2860
ACE2 improves right ventricular function in a pressure overload model.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
ACE2 improves right ventricular function in a pressure overload model.
@ast
ACE2 improves right ventricular function in a pressure overload model.
@en
type
label
ACE2 improves right ventricular function in a pressure overload model.
@ast
ACE2 improves right ventricular function in a pressure overload model.
@en
prefLabel
ACE2 improves right ventricular function in a pressure overload model.
@ast
ACE2 improves right ventricular function in a pressure overload model.
@en
P2093
P2860
P1433
P1476
ACE2 improves right ventricular function in a pressure overload model.
@en
P2093
Anna R Hemnes
James West
Jennifer A Johnson
Karen B Maynard
P2860
P304
P356
10.1371/JOURNAL.PONE.0020828
P407
P577
2011-06-10T00:00:00Z